Cahill Financial Advisors’s Amgen AMGN Stock Holding History

Cahill Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$346K	Buy	956 +1	+0.1%	+$342	0.03%	231
2026 Q1	$336K	Hold	955	–	–	0.04%	227
2025 Q4	$313K	Sell	955 -103	-10%	-$32.7K	0.03%	238
2025 Q3	$299K	Buy	+1,058	New	+$307K	0.03%	240
2025 Q2	–	Sell	-657	Closed	-$205K	–	274
2025 Q1	$205K	Buy	+657	New	+$194K	0.03%	259
2024 Q1	–	Sell	-1,045	Closed	-$301K	–	260
2023 Q4	$301K	Buy	+1,045	New	+$285K	0.04%	198

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cahill Financial Advisors's AMGN Position: Q2 2026 in Review

Cahill Financial Advisors increased its Amgen (AMGN) stake by 0.1% in Q2 2026, buying an estimated $342 and bringing the position to 956 shares worth $346K. The position accounts for 0.03% of the portfolio, ranked #231.

Cahill Financial Advisors first reported a position in AMGN in Q4 2023 and has held it in 6 quarters since. 3,163 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Cahill Financial Advisors held 956 shares of Amgen worth $346K as of Q2 2026.
Cahill Financial Advisors bought 1 Amgen share in Q2 2026, an estimated $342.
Amgen made up 0.03% of Cahill Financial Advisors's portfolio in Q2 2026, its #231 holding.
Cahill Financial Advisors first reported a position in Amgen in Q4 2023 and has held it in 6 quarters since.
3,163 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cahill Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.